Status:
UNKNOWN
Superior vs Temporal Laser Peripheral Iridotomy in Primary Angle Closure Suspects (PACS)
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Primary Angle Glaucoma Closure Suspect
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Basic Study Design: Prospective, randomized, single-center, single-blinded study to compare dysphotopsias and pain recollection immediately 2 weeks, and 3 months after LPI in PACS patients who have a ...
Detailed Description
The study objective is to describe the difference in the incidence of dysphotopsias and sensation of pain both immediately, 2 weeks and 3 months after superior or temporal LPI. The main primary outcom...
Eligibility Criteria
Inclusion
- \* clinical evidence of bilateral occludable angles (PACS) defined as:
- Peripheral anterior synechia (PAS) absent and trabecular meshwork not visible in ≥6 clock hours under non-indentation gonioscopy, Along with,
- absence of PAC or PACG, in both eyes.
- macular and optic nerve OCT within the 95% range of the normative database for patients to be included in this study.
Exclusion
- evidence of unilateral PACS,
- a history suggestive of an acute angle closure attack (based on symptoms) documented intraocular pressure over 30 mmHg,
- or any sign of Angle Closure Glaucoma (manifest glaucomatous neuropathy detected by OCT).
- Patients with previous ocular surgeries will also be excluded.
Key Trial Info
Start Date :
November 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04741919
Start Date
November 25 2020
End Date
December 31 2024
Last Update
April 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5